Many individuals seeking asylum in the United States show increased stress and pain symptoms that are associated with indications of cardiovascular disease according to Weill Cornell Medicine researchers.
Q&A: FDA’s Peter Marks ready to encourage more accelerated approvals for rare diseases
FDA biologics center director Peter Marks said the agency plans to encourage sponsors to use the accelerated approval pathway, particularly for rare disease treatments, as
August 17, 2023